Raras
Buscar doenças, sintomas, genes...
Distrofia em padrão
ORPHA:63454DOENÇA RARA

A distrofia muscular de Duchenne (DMD) é um tipo grave de distrofia muscular que afeta principalmente recém-nascidos do sexo masculino. A fraqueza muscular inicia-se geralmente por volta dos quatro anos de idade e progride rapidamente. A atrofia muscular geralmente ocorre primeiro nas coxas e na região pélvica, seguindo-se os membros superiores. Esta degeneração pode originar dificuldade em levantar-se. A maioria dos indivíduos perde a capacidade de andar até aos 12 anos de idade. Os músculos afetados podem parecer maiores devido ao aumento do teor de gordura.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Distrofia em padrão é uma condição ocular rara que afeta a retina, podendo causar perda de visão central, distorção visual e sensibilidade à luz. Pode estar associada a deficiência intelectual e insuficiência ovariana prematura, com herança autossômica dominante ou recessiva.

Publicações científicas
236 artigos
Último publicado: 2026 Mar 30

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Início
Adult
🏥
SUS: Sem cobertura SUSScore: 0%
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

👁️
Olhos
8 sintomas
❤️
Coração
1 sintomas
🧠
Neurológico
1 sintomas
📏
Crescimento
1 sintomas
🧬
Pele e cabelo
1 sintomas
💪
Músculos
1 sintomas

+ 7 sintomas em outras categorias

Características mais comuns

Insuficiência ovariana prematura
Neovascularização coroide
Fotofobia
Metamorfopsia
Deficiência intelectual, leve
Nictalopia
21sintomas
Sem dados (21)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 21 características clínicas mais associadas, ordenadas por frequência.

Insuficiência ovariana prematuraPremature ovarian insufficiency
Neovascularização coroideChoroidal neovascularization
FotofobiaPhotophobia
MetamorfopsiaMetamorphopsia
Deficiência intelectual, leveIntellectual disability, mild

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico236PubMed
Últimos 10 anos123publicações
Pico202416 papers
Linha do tempo
2026Hoje · 2026🧪 2006Primeiro ensaio clínico📈 2024Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

5 genes identificados com associação a esta condição. Padrão de herança: Autosomal dominant, Autosomal recessive.

PRPH2Peripherin-2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Essential for retina photoreceptor outer segment disk morphogenesis, may also play a role with ROM1 in the maintenance of outer segment disk structure (By similarity). Required for the maintenance of retinal outer nuclear layer thickness (By similarity). Required for the correct development and organization of the photoreceptor inner segment (By similarity)

LOCALIZAÇÃO

MembraneCell projection, cilium, photoreceptor outer segmentPhotoreceptor inner segment

MECANISMO DE DOENÇA

Retinitis pigmentosa 7

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
9.3 TPM
Ovário
6.8 TPM
Cervix Ectocervix
5.7 TPM
Pituitária
5.3 TPM
Músculo esquelético
5.0 TPM
OUTRAS DOENÇAS (13)
retinitis pigmentosa 7vitelliform macular dystrophy 3fundus albipunctatuschoroidal dystrophy, central areolar 2
HGNC:9942UniProt:P23942
CTNNA1Catenin alpha-1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Associates with the cytoplasmic domain of a variety of cadherins. The association of catenins to cadherins produces a complex which is linked to the actin filament network, and which seems to be of primary importance for cadherins cell-adhesion properties. Can associate with both E- and N-cadherins. Originally believed to be a stable component of E-cadherin/catenin adhesion complexes and to mediate the linkage of cadherins to the actin cytoskeleton at adherens junctions. In contrast, cortical ac

LOCALIZAÇÃO

Cytoplasm, cytoskeletonCell junction, adherens junctionCell membraneCell junctionCytoplasmNucleus

VIAS BIOLÓGICAS (6)
VEGFR2 mediated vascular permeabilityRegulation of CDH11 functionCDH11 homotypic and heterotypic interactionsRegulation of CDH19 Expression and FunctionRHO GTPases activate IQGAPs
EXPRESSÃO TECIDUAL(Ubíquo)
Nervo tibial
263.7 TPM
Artéria tibial
233.0 TPM
Aorta
223.1 TPM
Esôfago - Mucosa
193.9 TPM
Pulmão
190.6 TPM
OUTRAS DOENÇAS (3)
patterned macular dystrophy 2hereditary diffuse gastric adenocarcinomabutterfly-shaped pigment dystrophy
HGNC:2509UniProt:P35221
RCBTB1RCC1 and BTB domain-containing protein 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

May be involved in cell cycle regulation by chromatin remodeling

LOCALIZAÇÃO

Nucleus

MECANISMO DE DOENÇA

Retinal dystrophy with or without extraocular anomalies

An autosomal recessive disease characterized by progressive retinal dystrophy, chorioretinal macular atrophy, reduced cone and rod responses on ERG, and decrease visual acuity. Extraocular anomalies are variably present in some patients and include pulmonary fibrosis, sensorineural hearing loss, and endocrine features such as goiter and primary ovarian insufficiency.

EXPRESSÃO TECIDUAL(Ubíquo)
Tireoide
77.1 TPM
Brain Spinal cord cervical c-1
37.8 TPM
Glândula adrenal
33.7 TPM
Útero
30.5 TPM
Substância negra
29.0 TPM
INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (2)
RCBTB1-related retinopathyreticular dystrophy of the retinal pigment epithelium
HGNC:18243UniProt:Q8NDN9
OTX2Homeobox protein OTX2Candidate gene tested inAltamente restrito
FUNÇÃO

Transcription factor probably involved in the development of the brain and the sense organs. Can bind to the bicoid/BCD target sequence (BTS): 5'-TCTAATCCC-3'

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (2)
Formation of the posterior neural plateFormation of the anterior neural plate
MECANISMO DE DOENÇA

Microphthalmia, syndromic, 5

Patients manifest unilateral or bilateral microphthalmia/clinical anophthalmia and variable additional features including pituitary dysfunction, coloboma, microcornea, cataract, retinal dystrophy, hypoplasia or agenesis of the optic nerve, agenesis of the corpus callosum, developmental delay, joint laxity, hypotonia, and seizures. Microphthalmia is a disorder of eye formation, ranging from small size of a single eye to complete bilateral absence of ocular tissues (anophthalmia). In many cases, microphthalmia/anophthalmia occurs in association with syndromes that include non-ocular abnormalities.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
24.4 TPM
Cerebelo
23.8 TPM
Substância negra
2.9 TPM
Hipotálamo
1.0 TPM
Testículo
0.7 TPM
OUTRAS DOENÇAS (8)
pituitary hormone deficiency, combined, 6syndromic microphthalmia type 5septooptic dysplasiacombined pituitary hormone deficiencies, genetic form
HGNC:8522UniProt:P32243
MAPKAPK3MAP kinase-activated protein kinase 3Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Stress-activated serine/threonine-protein kinase involved in cytokines production, endocytosis, cell migration, chromatin remodeling and transcriptional regulation. Following stress, it is phosphorylated and activated by MAP kinase p38-alpha/MAPK14, leading to phosphorylation of substrates. Phosphorylates serine in the peptide sequence, Hyd-X-R-X(2)-S, where Hyd is a large hydrophobic residue. MAPKAPK2 and MAPKAPK3, share the same function and substrate specificity, but MAPKAPK3 kinase activity

LOCALIZAÇÃO

NucleusCytoplasm

VIAS BIOLÓGICAS (2)
Oxidative Stress Induced Senescenceactivated TAK1 mediates p38 MAPK activation
MECANISMO DE DOENÇA

Macular dystrophy, patterned, 3

A form of retinal patterned dystrophy, characterized by retinal pigment epithelium and Bruch's membrane changes resembling a 'dry desert land'. It begins around the age of 30 and progresses to retinitis pigmentosa. MDPT3 inheritance is autosomal dominant.

EXPRESSÃO TECIDUAL(Ubíquo)
Coração - Ventrículo esquerdo
119.5 TPM
Músculo esquelético
98.5 TPM
Coração - Átrio
75.7 TPM
Tireoide
56.5 TPM
Skin Sun Exposed Lower leg
55.8 TPM
OUTRAS DOENÇAS (1)
patterned macular dystrophy 3
HGNC:6888UniProt:Q16644

Variantes genéticas (ClinVar)

224 variantes patogênicas registradas no ClinVar.

🧬 MAPKAPK3: GRCh37/hg19 3p26.3-14.3(chr3:2263690-55016039)x3 ()
🧬 MAPKAPK3: GRCh37/hg19 3p21.31-21.2(chr3:48855503-51285217)x3 ()
🧬 MAPKAPK3: NM_001243925.2(MAPKAPK3):c.900C>G (p.Asn300Lys) ()
🧬 MAPKAPK3: NC_000003.11:g.(?_49547968)_(50685477_?)del ()
🧬 MAPKAPK3: GRCh37/hg19 3p21.31-21.2(chr3:48807193-51363558)x1 ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 2 variantes classificadas pelo ClinVar.

2
Patogênica (100.0%)
VARIANTES MAIS SIGNIFICATIVAS
PRPH2: NM_000322.5(PRPH2):c.463_467dup (p.Asp157fs) [Pathogenic]
PRPH2: NM_000322.5(PRPH2):c.945del (p.Trp316fs) [Pathogenic]

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
3Fase 31
·Pré-clínico3
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 4 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Distrofia em padrão

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

4 ensaios clínicos encontrados.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
125 papers (10 anos)
#1

A heterozygous pathogenic RPE65 variant phenocopies a mitochondrial retinopathy.

Ophthalmic genetics2026 Mar 17

The gene retinoid isomerohydrolase retinal pigment epithelium 65 (RPE65; OMIM# 180069), is abundantly expressed in the RPE and encodes an isomerohydrolase enzyme that catalyzes an essential step in the visual cycle by converting all-trans retinyl ester to 11-cis retinol. Most pathogenic variants in RPE65 are loss-of-function and have been associated with autosomal recessive inherited retinal diseases (IRD) such as Leber congenital amaurosis (LCA; OMIM# 204100) or retinitis pigmentosa (RP) 20 (OMIM# 613794). Both of these biallelic RPE65-associated conditions can be treated with an ocular gene therapy known as Luxturna (Voretigene neparvovec-rzyl) but, owing to different pathomechanisms, autosomal dominant forms of RPE65-associated IRDs do not have an approved therapy. The best characterized autosomal dominant RPE65 variant is of Irish origin, p.(Asp477Gly), but a novel autosomal dominant variant of Belgian origin has recently been identified that causes a macular pattern dystrophy resembling that occurring in maternally inherited diabetes and deafness (MIDD), with chorioretinal atrophy as a hallmark. Here, we describe the case of a 67-year-old Belgian patient presenting with progressive vision loss and macular pattern dystrophy resembling MIDD, which was found to be caused by the same heterozygous variant in RPE65 identified by Van Vooren and colleagues. We emphasize the importance of considering RPE65 heterozygosity in cases resembling MIDD with negative mitochondrial genome sequencing. In addition, we highlight outer retinal tubulations (ORTs) as an optical coherence tomography feature in our patient, like some cases of MIDD, supporting an overlapping clinical phenotype.

#2

Long-read sequencing uncovers novel pathogenic duplications in the PRPH2 gene in patients with macular dystrophy.

Ophthalmic genetics2026 Feb

Clinical variability and incomplete penetrance characterize retinal dystrophies associated with PRPH2 gene variants. Here, we utilized adaptive nanopore long-read sequencing (LRS) to solve a genetic diagnosis for dominantly inherited macular dystrophies in two families. Patient 1 (P1) and her daughter, Patient 2 (P2) were clinically evaluated using multimodal imaging and electrophysiological testing at Helsinki University Hospital, Finland, and Patient 3 (P3) from a different family, at Loma Linda University, USA. The patients were subjected to retinal dystrophy gene panels and the suspected duplications were characterized with nanopore LRS. P1 presented with butterfly-shaped pattern dystrophy (BPD) and P2 with vitelliform macular dystrophy. P3 showed BPD in the right eye and late-stage BPD in the left. Gene panels suggested that the patients shared the same heterozygous 482 bp PRPH2 exon 2 duplication. LRS revealed the duplications to be almost 4kb in size with breakpoints (BP) in intronic Alu-elements. In P1 and P2, the 3'BP resides within a novel Alu-element. The duplication has not been reported earlier and is missing from the gnomAD database. This study presents novel PRPH2 exon 2 duplications associated with macular dystrophies.

#3

Expanding the Genetic Spectrum in IMPG1 and IMPG2 Retinopathy.

Genes2025 Dec 09

Background: Pathogenic variants in interphotoreceptor matrix proteoglycan 1 (IMPG1) have been associated with autosomal dominant and recessive retinitis pigmentosa (RP) and autosomal dominant adult vitelliform macular dystrophy (AVMD). Monoallelic pathogenic variants in IMPG2 have been linked to maculopathy and biallelic variants to RP with early onset macular atrophy. Herein we characterise the phenotypic and genotypic features of patients with IMPG1/IMPG2 retinopathy and report novel variants. Methods: Patients with IMPG1 and IMPG2 variants and compatible phenotypes were retrospectively identified. Clinical data were obtained from reviewing the medical records. Phenotypic data included visual acuity, imaging included ultra-widefield pseudo-colour, fundus autofluorescence, and optical coherence tomography (OCT). Genetic testing was performed using next generation sequencing (NGS). Variant pathogenicity was investigated using in silico analysis (SIFT, PolyPhen-2, mutation taster, SpliceAI). The evolutionary conservation of novel missense variants was also investigated. Results: A total of 13 unrelated patients were identified: 2 (1 male; 1 female) with IMPG1 retinopathy and 11 (7 male; 4 female) with IMPG2 retinopathy. Both IMPG1 retinopathy patients were monoallelic: one patient had adult vitelliform macular dystrophy (AVMD) with drusenoid changes while the other had pattern dystrophy (PD), and they presented to clinic at age 81 and 72 years, respectively. There were 5 monoallelic IMPG2 retinopathy patients with a maculopathy phenotype, of whom 1 had PD and 4 had AVMD. The mean age of symptom onset of this group was 54.2 ± 11.8 years, mean age at presentation was 54.8 ± 11.5 years, and mean BCVAs were 0.15 ± 0.12 logMAR OD and -0.01 ± 0.12 logMAR OS. Six biallelic IMPG2 patients had RP with maculopathy, where the mean age of onset symptom onset was 18.4 years, mean age at examination was 68.7 years, and mean BCVAs were 1.90 logMAR OD and 1.82 logMAR OS. Variants in IMPG1 included one missense and one exon deletion. A total of 11 different IMPG2 variants were identified (4 missense, 7 truncating). A splicing defect was predicted for the c.871C>A p.(Arg291Ser) missense IMPG2 variant. One IMPG1 and five IMPG2 variants were novel. Conclusions: This study describes the phenotypic spectrum of IMPG1/IMPG2 retinopathy and six novel variants are reported. The phenotypes of PD and AVMD in monoallelic IMPG2 patients may result from haploinsufficiency, supported by the presence of truncating variants in both monoallelic and biallelic cases. The identification of novel variants expands the known genetic landscape of IMPG1 and IMPG2 retinopathies. These findings contribute to diagnostic accuracy, informed patient counselling regarding inheritance pattern, and may help guide recruitment for future therapeutic interventions.

#4

Clinical insights into mitochondrial retinopathy: A case report on m.3243A>G mutation and macular dystrophy.

Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society2025

Mitochondrial disorders, particularly those associated with the m.3243A>G mutation in the MT-TL1 gene, can manifest with diverse systemic and ocular features, including mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) and maternally inherited diabetes and deafness. Retinal involvement often presents as macular pattern dystrophy. A 65-year-old female with a known history of mitochondrial disease (m.3243A>G mutation) presented for evaluation of retinal findings. She had asymptomatic diabetes and deafness, with visual acuity measured at 0.12 bilaterally. Clinical examination revealed clear corneas, nonsignificant cataracts, and fundoscopic findings of patchy retinal and parafoveal atrophy with preserved foveal regions. Optical coherence tomography indicated a preserved fovea, but thinning of perifoveal layers. The findings suggest retinal dystrophy indicative of mitochondrial retinopathy, characterized by macular pattern dystrophy associated with the m.3243A>G mutation. Given the potential for varied clinical presentations linked to this mutation, multidisciplinary evaluations are essential to assess systemic involvement and facilitate appropriate management. This case underscores the importance of recognizing retinal manifestations in patients with mitochondrial disorders, particularly in those with the m.3243A>G mutation, and highlights the need for comprehensive monitoring and care.

#5

Evaluating the clinical utility of multimodal large language models in rare maculopathy.

Scientific reports2025 Dec 03

This study aimed to assess how multimodal large language models (MLLM) diagnose and differentiate Pentosan Polysulfate (PPS) Maculopathy from other phenotypic mimics. A retrospective review of clinical records and multimodal retinal imaging was conducted with patients from the Shiley Eye Institute and Casey Eye Institute. Four MLLMs (ChatGPT-4o, Claude 3.5 Sonnet, Google Gemini 1.5 Pro, Perplexity Llama 3.1 Sonar/Default) along with human retinal specialists answered prompts based on retinal imaging and demographic data. Performance was evaluated using accuracy, sensitivity and specificity estimates. The study included 126 eyes from 63 patients, with 36 eyes with PPS maculopathy, 50 eyes with Stargardt disease, and 40 eyes with PRPH2-associated multifocal pattern dystrophy. MLLMs showed improved accuracy and sensitivity when answer choices were restricted, with ChatGPT consistently performing best when all imaging modalities were prompted together. The inclusion of demographic data further enhanced performance in prompts with limited answer choices. Human retinal specialist evaluations aligned with MLLM performance trends and also improved with demographic data. While MLLMs show diagnostic potential, further refinement is needed before clinical implementation. These findings highlight the importance of prompt design and demographic data to optimize MLLM performance with retinal imaging modalities.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC89 artigos no totalmostrando 121

2026

A heterozygous pathogenic RPE65 variant phenocopies a mitochondrial retinopathy.

Ophthalmic genetics
2025

Expanding the Genetic Spectrum in IMPG1 and IMPG2 Retinopathy.

Genes
2025

Clinical insights into mitochondrial retinopathy: A case report on m.3243A>G mutation and macular dystrophy.

Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society
2025

Evaluating the clinical utility of multimodal large language models in rare maculopathy.

Scientific reports
2026

Long-read sequencing uncovers novel pathogenic duplications in the PRPH2 gene in patients with macular dystrophy.

Ophthalmic genetics
2025

Genotype-Phenotype Correlations in PRPH2 Retinopathies: A Comprehensive Analysis of 36 Patients from the Oxford Eye Hospital, UK.

Genes
2025

CTNNA1-associated retinal dystrophy: novel multimodal imaging and electrophysiology features.

Documenta ophthalmologica. Advances in ophthalmology
2025

RPE65 variant p.(E519K) causes a novel dominant adult-onset maculopathy in 83 affected individuals.

Research square
2025

Butterfly-shaped pattern dystrophy complicated by retinal pigment epithelium tear - case report.

European journal of ophthalmology
2025

LONG-TERM OUTCOMES OF ANTI-VEGF THERAPY FOR MACULAR NEOVASCULARIZATION IN PRPH2-ASSOCIATED RETINOPATHY.

Retina (Philadelphia, Pa.)
2025

Foveal crack sign and macular pattern dystrophy.

International journal of retina and vitreous
2025

Retrospective audit reviewing accuracy of clinical diagnosis of geographic atrophy in a single centre private tertiary retinal practice in Australia.

Scientific reports
2024

Clinical and Imaging Characteristics of PRPH2 Retinopathies in a Longitudinal Cohort and Diagnostic Implications.

Investigative ophthalmology &amp; visual science
2025

PRPH2-ASSOCIATED RETINAL DISEASES: A SYSTEMATIC REVIEW OF PHENOTYPIC FINDINGS.

American journal of ophthalmology
2024

A new mouse model for PRPH2 pattern dystrophy exhibits functional compensation prior and subsequent to retinal degeneration.

Human molecular genetics
2025

LONG-TERM FOLLOW-UP OF A FAMILY WITH A3243G MITOCHONDRIAL SYNDROME.

Retinal cases &amp; brief reports
2025

Using Multimodal Imaging to Refine the Phenotype of PRPH2-associated Retinal Degeneration.

Ophthalmology. Retina
2024

Novel Variants in ABCA4-Related Retinopathies with Structural Re-Assessment of Variants of Uncertain Significance.

Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde
2024

Non-syndromic OTX2-associated pattern dystrophy: a 10-year multimodal imaging study.

Documenta ophthalmologica. Advances in ophthalmology
2024

Detailed Phenotype Supports Pathogenicity of Hypomorphic Variant in ABCC6-Associated Pattern Dystrophy.

Case reports in ophthalmology
2024

Glycogen myophosphorylase loss causes increased dependence on glucose in iPSC-derived retinal pigment epithelium.

The Journal of biological chemistry
2023

Adult-onset foveomacular vitelliform dystrophy: epidemiology, pathophysiology, imaging, and prognosis.

Frontiers in ophthalmology
2024

Establishment of an induced pluripotent stem cell line LEIi019-A from an early-onset retinal dystrophy patient with the autosomal dominant OTX2 c.259G>A variant.

Stem cell research
2024

Retinal Dystrophies Associated With Peripherin-2: Genetic Spectrum and Novel Clinical Observations in 241 Patients.

Investigative ophthalmology &amp; visual science
2024

Optical Coherence Tomography in Inherited Macular Dystrophies: A Review.

Diagnostics (Basel, Switzerland)
2024

Late-onset Kjellin syndrome: Diagnosis of SPG11 on fundus examination.

European journal of ophthalmology
2024

Novel heterozygous PRPH2 variant identified in a patient with spinocerebellar ataxia type 14 and macular dystrophy.

Ophthalmic genetics
2024

A Retrospective Longitudinal Study of 460 Patients with ABCA4-Associated Retinal Disease.

Ophthalmology
2024

Phenotyping and genotyping inherited retinal diseases: Molecular genetics, clinical and imaging features, and therapeutics of macular dystrophies, cone and cone-rod dystrophies, rod-cone dystrophies, Leber congenital amaurosis, and cone dysfunction syndromes.

Progress in retinal and eye research
2023

Diagnostic Challenges in ABCA4-Associated Retinal Degeneration: One Gene, Many Phenotypes.

Diagnostics (Basel, Switzerland)
2024

Quantitative microvascular alterations in butterfly-shaped pattern dystrophy and adult-onset foveomacular vitelliform dystrophy.

Journal francais d'ophtalmologie
2024

The Retinal Phenotype Associated with the p.Pro101Thr BEST1 Variant.

Ophthalmology. Retina
2023

α-catenin mechanosensitivity as a route to cytokinesis failure through sequestration of LZTS2.

bioRxiv : the preprint server for biology
2023

Choroidal neovascularization associated with butterfly-shaped pattern dystrophy - a case report.

Romanian journal of ophthalmology
2023

Comparative study of PRPH2 D2 loop mutants reveals divergent disease mechanism in rods and cones.

Cellular and molecular life sciences : CMLS
2023

A rare association between angioid streaks and pattern dystrophy.

Arquivos brasileiros de oftalmologia
2023

PRPH2 mutation c.582-1G>A causing adult-onset macular dystrophy with a benign concentric annular macular dystrophy phenotype in a family.

Arquivos brasileiros de oftalmologia
2023

Electrophysiological Evaluation of Macular Dystrophies.

Journal of clinical medicine
2023

Vitelliform maculopathy: Diverse etiologies originating from one common pathway.

Survey of ophthalmology
2023

PRPH2-Associated Retinopathy: Novel Variants and Genotype-Phenotype Correlations.

Ophthalmology. Retina
2023

Incidence and Risk Factors of Visual Impairment in Patients with Angioid Streaks and Macular Neovascularization.

Ophthalmology. Retina
2022

Kjellin's syndrome: Spastic paraplegia and multifocal pattern dystrophy simulating fundus flavimaculatus.

Archivos de la Sociedad Espanola de Oftalmologia
2024

LONG-TERM FOLLOW-UP OF PRPH2 -ASSOCIATED RETINAL DYSTROPHY.

Retinal cases &amp; brief reports
2022

PATTERN DYSTROPHY-LIKE CHANGES ASSOCIATED WITH A VERY HIGH SERUM FERRITIN LEVEL IN β-THALASSEMIA MAJOR.

Retinal cases &amp; brief reports
2023

Longitudinal Analysis of Functional and Structural Outcome Measures in PRPH2-Associated Retinal Dystrophy.

Ophthalmology. Retina
2023

Blue-light fundus autofluorescence imaging of pigment epithelial detachments.

Eye (London, England)
2022

Age-Related Macular Degeneration Masquerade: A Review of Pentosan Polysulfate Maculopathy and Implications for Clinical Practice.

Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)
2021

Deep Learning to Distinguish ABCA4-Related Stargardt Disease from PRPH2-Related Pseudo-Stargardt Pattern Dystrophy.

Journal of clinical medicine
2022

PRPH2-Associated Macular Dystrophy in 4 Family Members with a Novel Mutation.

Ophthalmic genetics
2021

A Case Report of Pseudoxanthoma Elasticum with Rare Sequence Variants in Genes Related to Inherited Retinal Diseases.

Diagnostics (Basel, Switzerland)
2023

Primary and secondary focal choroidal excavation morphologic phenotypes, associated ocular disorders and prognostic implications.

The British journal of ophthalmology
2021

Multifocal Pattern Dystrophy Simulating Fundus Flavimaculatus: Multimodal Imaging for Early Diagnosis.

Case reports in ophthalmology
2022

Optical coherence tomography findings and choroidal neovascular membrane detectability with optical coherence tomography angiography in different subtypes of pattern dystrophy.

Clinical &amp; experimental optometry
2021

Treatment and longitudinal follow-up of CNV associated with pattern dystrophy with novel PRPH2 variant.

Ophthalmic genetics
2022

Near infrared autofluorescence imaging of retinal pigmented epithelial cells using 663 nm excitation.

Eye (London, England)
2021

Multimodal Imaging in a Case with Bilateral Choroidal Folds.

Case reports in ophthalmology
2022

Expanded Clinical Spectrum of Pentosan Polysulfate Maculopathy: A Macula Society Collaborative Study.

Ophthalmology. Retina
2021

Clinical and molecular findings in patients with pattern dystrophy.

Ophthalmic genetics
2021

Phenotypic Features and Genetic Findings in a Cohort of Italian Pseudoxanthoma Elasticum Patients and Update of the Ophthalmologic Evaluation Score.

Journal of clinical medicine
2023

NOVEL PRPH2/RDS MUTATION IDENTIFIED IN A FAMILY WITH VARYING CLINICAL MANIFESTATIONS: A CASE REPORT.

Retinal cases &amp; brief reports
2021

Comparing Fluorescence Lifetime Imaging Ophthalmoscopy in Atrophic Areas of Retinal Diseases.

Translational vision science &amp; technology
2021

Fundus flavimaculatus-like in myotonic dystrophy: a case report.

BMC ophthalmology
2021

Unusual clinical phenotype of Stargardt disease.

Arquivos brasileiros de oftalmologia
2022

Pentosan polysulfate maculopathy.

Survey of ophthalmology
2020

Retinal imaging in inherited retinal diseases.

Annals of eye science
2022

Novel BEST1 mutations and clinical characteristics of autosomal recessive bestrophinopathy in a Spanish patient.

European journal of ophthalmology
2021

Neuro-ophthalmic manifestations of mitochondrial disorders and their management.

Taiwan journal of ophthalmology
2021

Deep learning-based classification of retinal atrophy using fundus autofluorescence imaging.

Computers in biology and medicine
2021

Clinical and Genetic Findings in CTNNA1-Associated Macular Pattern Dystrophy.

Ophthalmology
2020

PRPH2-Related Retinal Diseases: Broadening the Clinical Spectrum and Describing a New Mutation.

Genes
2020

Unilateral pattern of macular dystrophy and associated systemic pathology.

Archivos de la Sociedad Espanola de Oftalmologia
2020

Quantitative Fundus Autofluorescence and Genetic Associations in Macular, Cone, and Cone-Rod Dystrophies.

Ophthalmology. Retina
2020

A Family Affected by Novel C213W Mutation in PRPH2: Long-Term Follow-Up of CNV Secondary to Pattern Dystrophy.

Ophthalmic surgery, lasers &amp; imaging retina
2020

Pattern dystrophy-like changes and coquille d'oeuf atrophy in elderly patients affected by pseudoxanthoma elasticum.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
2020

Clinical phenotype of mitochondrial diabetes due to rare mitochondrial DNA mutations.

Annales d'endocrinologie
2020

Anti-VEGF and Retinal Dystrophies.

Current drug targets
2021

INTRARETINAL HYPERREFLECTIVE LINES.

Retina (Philadelphia, Pa.)
2020

Macular hole and serous pigment epithelial detachment in bilateral acquired vitelliform lesions.

American journal of ophthalmology case reports
2020

Longitudinal case study and phenotypic multimodal characterization of McArdle disease-linked retinopathy: insight into pathomechanisms.

Ophthalmic genetics
2020

Spectral domain optical coherence tomography findings in myotonic dystrophy.

Neuromuscular disorders : NMD
2020

Novel molecular mechanisms for Prph2-associated pattern dystrophy.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
2020

Outer retinal tubulation and inner retinal pseudocysts in a patient with maternally inherited diabetes and deafness evaluated with optical coherence tomography angiogram.

Indian journal of ophthalmology
2020

Macular dystrophies: clinical and imaging features, molecular genetics and therapeutic options.

The British journal of ophthalmology
2019

PRPH2 mutation as the cause of various clinical manifestations in a family affected with inherited retinal dystrophy.

Ophthalmic genetics
2019

Foveal Sparing in Central Retinal Dystrophies.

Investigative ophthalmology &amp; visual science
2019

Efficacy of anti-VEGF in the treatment of choroidal neovascular membrane secondary to pattern dystrophy simulating fundus flavimaculatus.

GMS ophthalmology cases
2019

Vasculitis and Retrofoveal Choroidal Neovessels in a Case of Multifocal Pattern Dystrophy.

Klinische Monatsblatter fur Augenheilkunde
2019

[Imaging of an atypical Butterfly Shaped Pattern dystrophy producing a "five-pointed star" appearance].

Journal francais d'ophtalmologie
2020

Retinal findings in carriers of monoallelic ABCC6 mutations.

The British journal of ophthalmology
2019

Case Series: Multimodal Imaging Reveals the Spectrum of Pattern Dystrophies of the Retinal Pigment Epithelium.

Optometry and vision science : official publication of the American Academy of Optometry
2019

Pattern Dystrophy: An Imprecise Diagnosis in the Age of Precision Medicine.

International ophthalmology clinics
2019

Anti-VEGF treatment for choroidal neovascularization complicating pattern dystrophy-like deposit associated with pseudoxanthoma elasticum.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
2019

EYES WITH SUBRETINAL DRUSENOID DEPOSITS AND NO DRUSEN: Progression of Macular Findings.

Retina (Philadelphia, Pa.)
2019

Optical coherence tomography angiography findings in a case of adult-onset vitelliform dystrophy.

Clinical &amp; experimental optometry
2018

Pattern dystrophies in patients treated with deferoxamine: report of two cases and review of the literature.

BMC ophthalmology
2021

RETINAL DYSTROPHY IN A PATIENT WITH McARDLE DISEASE.

Retinal cases &amp; brief reports
2018

Oligomerization of Prph2 and Rom1 is essential for photoreceptor outer segment formation.

Human molecular genetics
2019

Choroidal osteoma and pattern dystrophy of retinal pigment epithelium.

International ophthalmology
2017

Quantitative Fundus Autofluorescence in Pseudoxanthoma Elasticum.

Investigative ophthalmology &amp; visual science
2018

Clinical and imaging findings of pattern dystrophy subtypes; Diagnostic errors and unnecessary treatment in clinical practice.

Journal francais d'ophtalmologie
2018

Multimodal imaging of posterior ocular involvement in McArdle's disease.

Clinical &amp; experimental optometry
2017

The Nine-Step Minnesota Grading System for Eyebank Eyes With Age Related Macular Degeneration: A Systematic Approach to Study Disease Stages.

Investigative ophthalmology &amp; visual science
2017

Pseudovitelliform maculopathy associated with deferoxamine toxicity: multimodal imaging and electrophysiology of a rare entity.

Digital journal of ophthalmology : DJO
2018

THE EXPANDING CLINICAL SPECTRUM OF CHOROIDAL EXCAVATION IN MACULAR DYSTROPHIES.

Retina (Philadelphia, Pa.)
2017

The Evolution of Outer Retinal Tubulation, a Neurodegeneration and Gliosis Prominent in Macular Diseases.

Ophthalmology
2018

Multimodal imaging in a case of butterfly pattern dystrophy of retinal pigment epithelium.

International ophthalmology
2018

THE FUNDUS PHENOTYPE ASSOCIATED WITH THE p.Ala243Val BEST1 MUTATION.

Retina (Philadelphia, Pa.)
2017

Rom1 converts Y141C-Prph2-associated pattern dystrophy to retinitis pigmentosa.

Human molecular genetics
2016

Spontaneous Regression of Choroidal Neovascularization in a Patient with Pattern Dystrophy.

Case reports in ophthalmological medicine
2016

Pattern dystrophy in a female carrier of RP2 mutation.

Ophthalmic genetics
2015

Comet Lesions in Patients with Pseudoxanthoma Elasticum.

Turkish journal of ophthalmology
2016

β-Thalassemia and ocular implications: a systematic review.

BMC ophthalmology
2016

Multimodal imaging in multifocal pattern dystrophy simulating fundus flavimaculatus.

Indian journal of ophthalmology
2016

Frequency, Phenotypic Characteristics and Progression of Atrophy Associated With a Diseased Bruch's Membrane in Pseudoxanthoma Elasticum.

Investigative ophthalmology &amp; visual science
2016

The K153Del PRPH2 mutation differentially impacts photoreceptor structure and function.

Human molecular genetics
2017

Vitelliform dystrophies: Prevalence in Olmsted County, Minnesota, United States.

Ophthalmic genetics
2016

Evaluation of the association of single nucleotide polymorphisms in the PRPH2 gene with adult-onset foveomacular vitelliform dystrophy.

Ophthalmic genetics
2016

RDS Functional Domains and Dysfunction in Disease.

Advances in experimental medicine and biology
2015

Macular pattern dystrophy and homonymous hemianopia in MELAS syndrome.

BMJ case reports
2015

Adult-onset foveomacular vitelliform dystrophy: A fresh perspective.

Progress in retinal and eye research
2015

Founder Effect of a c.828+3A&gt;T Splice Site Mutation in Peripherin 2 (PRPH2) Causing Autosomal Dominant Retinal Dystrophies.

JAMA ophthalmology

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Distrofia em padrão.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Distrofia em padrão

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. A heterozygous pathogenic RPE65 variant phenocopies a mitochondrial retinopathy.
    Ophthalmic genetics· 2026· PMID 41845931mais citado
  2. Long-read sequencing uncovers novel pathogenic duplications in the PRPH2 gene in patients with macular dystrophy.
    Ophthalmic genetics· 2026· PMID 41047250mais citado
  3. Expanding the Genetic Spectrum in IMPG1 and IMPG2 Retinopathy.
    Genes· 2025· PMID 41465146mais citado
  4. Clinical insights into mitochondrial retinopathy: A case report on m.3243A&gt;G mutation and macular dystrophy.
    Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society· 2025· PMID 41367844mais citado
  5. Evaluating the clinical utility of multimodal large language models in rare maculopathy.
    Scientific reports· 2025· PMID 41339423mais citado
  6. Identification of a founder mutation in the PRPH2 gene in an isolated Pacific Island population.
    Ophthalmic Genet· 2026· PMID 41912280recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:63454(Orphanet)
  2. MONDO:0018973(MONDO)
  3. GARD:9821(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Artigo Wikipedia(Wikipedia)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Distrofia em padrão
Compêndio · Raras BR

Distrofia em padrão

ORPHA:63454 · MONDO:0018973
Prevalência
Unknown
Herança
Autosomal dominant, Autosomal recessive
Início
Adult
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C1868569
EuropePMC
Wikipedia
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades